ABSTRACT
Salmonella-enteritis is known to be an infectious disease of world-wide epidemiologic importance. The treatment of chronic carriers of pathogenic salmonella has shown to be a major therapeutic problem. In a controlled clinical study the efficiency of Hylak forte (containing products of metabolism of symbiotic bacteria) in the management of salmonellosis in infants was investigated. In patients receiving Hylak forte the period of faecal excretion of salmonella was significantly (p = 0.0022) shortened in comparison with the control-group. No side-effects did occur. Hylak forte proved to be effective in the therapy of enteritis in infants; the period of excretion of salmonella was significantly reduced.
Subject(s)
Anti-Bacterial Agents/administration & dosage , Anti-Infective Agents , Diarrhea, Infantile/drug therapy , Feces/microbiology , Salmonella Infections/drug therapy , Salmonella enteritidis/drug effects , Salmonella typhimurium/drug effects , Colony Count, Microbial , Diarrhea, Infantile/microbiology , Female , Humans , Infant , Male , Organic Chemicals , Salmonella Infections/microbiology , Salmonella enteritidis/isolation & purification , Salmonella typhimurium/isolation & purificationABSTRACT
Centrifugation enhanced the infectivity of invasive Escherichia coli and Yersinia enterocolitica for HEp-2 cells. Noninvasive bacteria were not endocytosed after centrifugation. The centrifugation procedure may increase the sensitivity of testing for bacterial invasiveness in cell culture without causing false-positive results.
Subject(s)
Bacteriological Techniques , Escherichia coli/pathogenicity , Yersinia/pathogenicity , Adhesiveness , Cell Line , Centrifugation , Escherichia coli/growth & development , Humans , Yersinia/growth & developmentSubject(s)
Respiratory Tract Infections/etiology , Salmonella Infections , Age Factors , Humans , Infant , Infant, NewbornABSTRACT
The percentage of popliteal lymph node lymphocytes coated with anti-lymphocytic antibodies was defined by the immunofluorescent test. It was shown, that 4 hrs after ATS injection, 18-40% of lymphocytes in draining lymph node were coated with antibodies and gave positive fluorescence with rabbit anti-horse IgG FITC. There was no cells with antibodies in contralateral lymph node.
